RAM
TMDX icon

Revere Asset Management’s Transmedics TMDX Stock Holding History

Revere Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,845
Closed -$3.14M – 31
2024
Q2 		$3.14M Buy
+20,845
New +$2.5M 3.12% 11

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Revere Asset Management's TMDX Position: Q3 2024 in Review

Revere Asset Management sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 20,845 shares — an estimated $3.14M sold.

Revere Asset Management first reported a position in TMDX in Q2 2024 and held it in 1 quarter. The position peaked at $3.14M in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

  • Revere Asset Management reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
  • Revere Asset Management sold 20,845 Transmedics shares in Q3 2024, an estimated $3.14M.
  • Revere Asset Management first reported a position in Transmedics in Q2 2024 and held it in 1 quarter.
  • Revere Asset Management's Transmedics position peaked at $3.14M in Q2 2024.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Revere Asset Management's 13F filing for Q3 2024, filed 26 Feb 2026.